Speed is the product you actually sell
Win more bids on speed. Keep the margin on every study.
Syno gives every sponsor its own governed, isolated instance: unlimited seats, no per-head fee. Your biostatisticians ask in plain language and get back auditable, reproducible code, so you quote faster timelines, protect margin on fixed-price work, and never explain commingled data in an audit. It speeds the analysis-and-reporting leg of delivery. It won’t touch enrollment, monitoring, database lock, or sponsor sign-off, and we won’t pretend otherwise.
Isolated instance per sponsor · unlimited seats · audit trail on every analysis · ISO 27001 (in progress)
The business case
Four levers, in the language of your P&L.
Win bids on speed
Turnaround and AI-fluency have become bid tiebreakers, and sponsors now ask about them in RFIs. Quote faster analysis-and-reporting and compete where it counts.
Protect your margin
Every wrangling hour Syno removes is margin you keep on fixed-price work. Unlimited seats, no per-head fee.
Unlimited seats, no per-head fee
Put Syno in front of every biostatistician and proposal lead without watching a per-seat meter. The whole team works in it.
A governed instance per sponsor
Each sponsor sealed in its own attestable instance. Nothing to explain in a sponsor audit.
The ROI, honestly ranked
We won’t lead with “more trials per year.” You wouldn’t believe it.
Margin per study: bankable
A large share of biostat study-time, commonly cited at 30–50%, goes to data wrangling. If Syno takes a real bite out of it, every hour removed is margin you keep on fixed-price work. This is the lever to underwrite the decision on.
Win-rate: the upside
A couple of points of win-rate is roughly one more study a year, which can dwarf the subscription, provided the timeline gain is real and your proposals team uses it.
Capacity, where it applies
Freed time means more studies only where biostatistics is your binding constraint. Where it isn’t, you bank the time as margin and quote faster.
Model it on your numbers
Your bankable levers.
Switch on the work your team does. Each lever is a different team and deliverable, counted once. An estimate, not a quote; the figures stay in your browser.
The shared input
Studies per year drives the two per-study levers.
Defaults sit inside the 1.2–2× range independent studies report for AI code-generation on amenable tasks; it’s not a blanket multiple.
Build only — search, screening, extraction, a cited draft. Inclusion calls, appraisal and sign-off stay with your senior; every citation is DOI-checkable.
This is internal hours only, the conservative floor. The lever that clears €200k sits above it: with internal effort pushed down, you quote faster and win more bids, and the margin on one extra €0.5–2M study a year dwarfs anything modelled here. We size that against your P&L together. Book a deep dive →
A governed instance per sponsor
Nothing to explain in a sponsor audit.
Each sponsor is sealed in its own attestable instance, with a forwardable isolation pack their security team can review. The instance they pilot on is the same isolated architecture a sponsor would audit. There’s no separate “real” setup to explain later.
See isolation in the Trust Center →No commingled data. Each instance attestable on its own.
The Proof Pilot
Run it on one real study.
The Proof Pilot — €9,999, fixed.
Two months. Your own data, integrated into a dedicated Syno instance in our secure EU cloud. One question, a set end date, and a real finding your team keeps. The full €9,999 credits to your subscription if you continue, and you keep every result either way. The full DPA runs alongside.
Run it on a recently-closed study and you can check Syno against a result you already trust. We agree one success metric up front and tell you exactly what we need from your team, so €9,999 never hides an unfriendly project.
What we’ll need from you
- ✓About 8 hours of biostatistician time, total
- ✓One dataset, de-identified or synthetic
- ✓A security review that runs alongside, not first
- ✓One named contact on your side
The question on every CRO’s mind
“Doesn’t faster delivery cut our revenue?”
It changes what you compete on. Faster turnaround wins more bids, and unlimited seats let you take on more studies without adding headcount. On fixed-price work, every wrangling hour removed is margin you keep.
For the sponsor’s security team
A Trust Center you can forward.
Per-mode data-flow diagrams, the sub-processor list, audit-trail evidence, and the gated documents a sponsor review needs, all in one place your sponsor’s team can open.
Open the Trust Center →Frequently asked
Are we sealed off from other sponsors?
Yes. Each sponsor runs in its own isolated, attestable instance with a forwardable isolation pack their security team can review. The instance you pilot on is the same isolated architecture a sponsor would audit.
Doesn’t faster delivery cut our hours?
It changes what you compete on. Faster turnaround wins more bids, and unlimited seats let you take on more studies without adding headcount. The margin lever is bankable on fixed-price work today.
Are we your first CRO?
Yes, you’d be among the first. No CRO logo yet, and we won’t fake one. Founding partners get better pricing and a real say in the roadmap.
Quote faster on your next bid.
Try the live demo, model the margin on one of your studies, or run a pilot on a study you’ve already closed.